Last reviewed · How we verify
NCT05241366
TMS vs Conventional Therapy for the Treatment of Functional Neurological Non Epileptic Seizure Disorder
NA trial testing Transcranial Magnetic Stimulation in Psychogenic Non-Epileptic Seizure in 28 participants. Completed in 31 July 2023.
20 May 2023
Quick facts
| Lead sponsor | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 14 February 2022 |
| Primary completion | 20 May 2023 |
| Estimated completion | 31 July 2023 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Transcranial Magnetic Stimulation — full drug profile →
- Sham Transcranial Magnetic Stimulation coil
Conditions studied
- Psychogenic Non-Epileptic Seizure — all drugs for Psychogenic Non-Epileptic Seizure →
Sponsor
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez — full company profile →
Who can join
Adults 18 to 65, any sex, with Psychogenic Non-Epileptic Seizure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to compare the effect of Transcranial Magnetic Stimulation (TMS) versus treatment with selective serotonin reuptake inhibitors (SSRIs), in patients with diagnosis of Functional Neurological Non Epileptic Seizure Disorder (PNES).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05241366
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial Magnetic Stimulation
Trials testing the same drug.
- NCT07526285 — Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD) · NA · not yet recruiting
- NCT07050862 — rTMS for Tobacco Use in Veterans · NA · not yet recruiting
- NCT07145866 — Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study) · Phase 4 · not yet recruiting
- NCT07516028 — Brain Connectivity and Corticospinal Excitability in Response to Moderate Hypoxia · NA · not yet recruiting
- NCT07389694 — Using Transcranial Magnetic Stimulation to Treat Stuttering · NA · recruiting
Other El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez trials
Trials by the same sponsor.
- NCT06168838 — Anticoagulant-associated Intracranial Hemorrhage · unknown
- NCT06056349 — Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center · NA · recruiting
- NCT05219006 — Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures · NA · completed
- NCT03865121 — Pilot Trial of Transnasal Nicotine in Parkinson Disease · Phase 2 · completed
- NCT03627078 — Motor Interference Therapy For Traumatic Memories · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05241366 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05241366.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing